LBA42 POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
Sheela Rao, Jaume Capdevila, Duncan C. Gilbert, Stéfano Kim, Laëtitia Dahan, Talal Kayyal, Marwan Fakih, Anne Demols, Lars Henrik Jensen, K-L.G. Spindler, Dirk Arnold, Stefano Tamberi, Marianne G. Guren, Mark Cornfeld, Michael Jones, Chuan Tian, M. Catlett, J-P. Spano
Topics & Concepts
MedicineResponse Evaluation Criteria in Solid TumorsTolerabilityInternal medicinePembrolizumabProgressive diseaseSurgeryPhases of clinical researchGastroenterologyClinical endpointChemotherapyImmunotherapyOncologyCancerAdverse effectClinical trialColorectal and Anal CarcinomasCancer Immunotherapy and BiomarkersPeptidase Inhibition and Analysis